Skip to content
value.today
22Nd Century Group, Inc. logo

22Nd Century Group, Inc.

XXII
$0 Mmarket cap on Oct 29, 2026-96.0% since Jan 2024
Compare
World rank
#28,310
Revenue
$18 M
For year ending December-2025
Net income
$-5 M
-28.7% margin
SEC filing
Employees
67
As on 2020
value.today research

22Nd Century Group, Inc. in brief

22Nd Century Group, Inc. is a listed company in the Pharmaceutical industry, based in Williamsville, Indiana, USA. It was founded in 1998. Its market value was $0 M on 29 October 2026, which makes it the 28,310th largest listed company in the world and the 4,527th largest in the USA on this site. In the year to December 2025 it had sales of $18 M and a net loss of $5 M. It employs about 67 people and Lawrence Firestone is its chief executive. Its largest product and service lines by sales in 2025 were Contract Manufacturing (99%), Cigarettes (73%) and Filtered Cigars (23%). Its shares trade under the symbol XXII (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About 22Nd Century Group, Inc.

22nd Century Group is a Plant Biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene editing and modern plant breeding. The headquarters is in USA.

22nd Century Group company annual revenue was 62 million USD and annual net loss was -59 million USD as on Dec-2022.

22Nd Century Group, Inc. timeline

4 events, 1998–2022
  1. 1998
  2. 🏁
    · approximate
    Founded
  3. 2005
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2010
  6. ✎
    Renamed 22nd Century Group, Inc.
    Formerly Touchstone Mining LTD.
  7. 2022
  8. 💰
    Record revenue of $40 million
    FY2022, the highest of the 8 years on record.

Events of 22Nd Century Group, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$121 M$242 M$364 M$485 M2020202120222023202420252026

World rank over time

▼ down 11,341 places since 2020
2020-01-01: #16975#16,97520202021-01-01: #13596#13,59620212022-01-07: #14086#14,08620222022-12-25: #18292#18,29220222023-07-30: #24607#24,60720232024-01-05: #31601#31,60120242026-03-08: #13544#13,54420262026-08-01: #24081#24,08120262026-10-14: #28225#28,22520262026-10-29: #28316#28,3162026

Rank in USA: #3,417 (Jan 2020) · #2,934 (Jan 2021) · #3,030 (Jan 2022) · #3,729 (Dec 2022) · #4,654 (Jul 2023) · #4,557 (Jan 2024) · #2,486 (Mar 2026) · #4,172 (Aug 2026) · #4,458 (Oct 2026) · #4,530 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.0×
Price / book
0.0×
Free cash flow yield
-2431.2%
Net margin (TTM)
-27.0%
Operating margin
-65.8%
Return on equity
-24.9%
Liabilities / assets
31.6%
Net debt
$-6M
Revenue growth
-27.9%
R&D / revenue
3.9%
Revenue per employee
$263 K
Profit per employee
$-75 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $26M, net income $-8M$26MFY18Fiscal year ending Dec 2019: revenue $26M, net income $-27M$26MFY19Fiscal year ending Dec 2020: revenue $28M, net income $-20M$28MFY20Fiscal year ending Dec 2021: revenue $31M, net income $-33M$31MFY21Fiscal year ending Dec 2022: revenue $41M, net income $-60M$41MFY22Fiscal year ending Dec 2023: revenue $32M, net income $-141M$32MFY23Fiscal year ending Dec 2024: revenue $24M, net income $-15M$24MFY24Fiscal year ending Dec 2025: revenue $18M, net income $-5M$18MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$18M-27.9%$-12M$-5M-28.7%
Dec 2024$24M-24.3%$-14M$-15M-62.2%
Dec 2023$32M-20.5%$-45M$-141M-437.2%
Dec 2022$41M+30.9%$-34M$-60M-147.7%
Dec 2021$31M+10.1%$-28M$-33M-105.4%
Dec 2020$28M+8.8%$-19M$-20M-70.1%
Dec 2019$26M-2.3%$-24M$-27M-102.8%
Dec 2018$26M—$-24M$-8M-30.2%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-8M$0M$-8M$-52.87—
Dec 2024$-14M$0M$-14M$-45711.05—
Dec 2023$-55M$5M$-60M$-15925.99—
Dec 2022$-52M$4M$-55M$-4.65—
Dec 2021$-23M$1M$-24M$-0.21—
Dec 2020$-16M$0M$-16M$-0.14—
Dec 2019$-15M$1M$-15M$-0.21—
Dec 2018$-18M——$-0.06—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$15M
Net income, trailing 12 months
$-4M
RevenueNet income
Three months to Sep 2024: revenue $6M, net income $-4M$6MSep ’24Three months to Dec 2024 (from the annual report): revenue $4M, net income $-5M$4MDec ’24Three months to Mar 2025: revenue $6M, net income $-4M$6MMar ’25Three months to Jun 2025: revenue $4M, net income $-3M$4MJun ’25Three months to Sep 2025: revenue $4M, net income $5M$4MSep ’25Three months to Dec 2025 (from the annual report): revenue $4M, net income $-3M$4MDec ’25Three months to Mar 2026: revenue $4M, net income $-3M$4MMar ’26Three months to Jun 2026: revenue $3M, net income $-3M$3MJun ’26

Latest quarter to Jun 2026: revenue $3M (-29.9% on a year earlier), net income $-3M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of 22Nd Century Group, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$18 M
Operating income
$-12 M
Net income
$-5 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$27 M
Total liabilities
$9 M
Total equity
$16 M

As of December-2025

Top 19 institutional investors in 22Nd Century Group, Inc.#

As of Sep 30, 2026
19 institutions held 87,020 shares (about 12.2% of the shares outstanding) on Sep 30, 2026. The ten largest hold 12.2%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 19 largest institutional investors in 22Nd Century Group, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Anson Funds Management LP80,000+45,435 (+131.45%)11.20%$0 MNov 13, 2026
2UBS Group AG5,715+2,507 (+78.15%)0.80%$0 MNov 10, 2026
3Tower Research Capital LLC (TRC)1,199New0.17%$0 MNov 16, 2026
4Robinhood Markets, Inc.69—0.01%$0 MNov 18, 2026
5Caitong International Asset Management Co., Ltd8+7 (+700.00%)0.00%$0 MOct 29, 2026
6Morgan Stanley70 (0.00%)0.00%$0 MNov 13, 2026
7Osaic Holdings, Inc.7-1 (-12.50%)0.00%$0 MNov 12, 2026
8Fifth Third Bancorp20 (0.00%)0.00%$0 MNov 5, 2026
9Steward Partners Investment Advisory, LLC20 (0.00%)0.00%$0 MNov 13, 2026
10BlackRock, Inc.2+1 (+100.00%)0.00%$0 MNov 13, 2026
11Jpmorgan Chase & Co1New0.00%$0 MNov 12, 2026
12Barclays PLC1-163 (-99.39%)0.00%$0 MNov 6, 2026
13Northwestern Mutual Wealth Management Co1New0.00%$0 MNov 13, 2026
14Allworth Financial LP1New0.00%$0 MNov 17, 2026
15NewEdge Advisors, LLC10 (0.00%)0.00%$0 MNov 13, 2026
16IFP Advisors, Inc10 (0.00%)0.00%$0 MOct 16, 2026
17Gables Capital Management Inc.10 (0.00%)0.00%$0 MNov 4, 2026
18Kiker Wealth Management, LLC1New0.00%$0 MNov 16, 2026
19William Mack & Associates, Inc.1New0.00%$0 MOct 27, 2026

Insider trading at 22Nd Century Group, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
34
since
$34 K$0Jan 2024: bought $34 K (2 trades), sold $0 (0 trades)Jan 24May 2024: bought $10 K (1 trades), sold $0 (0 trades)MaySep 2024: bought $11 K (1 trades), sold $0 (0 trades)Sep
Bought (open market)Sold (open market)Hover a month for the totals
22Nd Century Group, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Andrew ArnoDirectorGrant or award+17,295——17,481Form 4
filed David N. KeysDirectorGrant or award+12,578——14,696Form 4
filed Jonathan StaffeldtVP and Deputy General CounselGrant or award+37,146——37,871Form 4
filed Lawrence FirestoneChief Executive Officer, DirectorGrant or award+66,824——68,129Form 4
filed Arvil S. MarionVP of Mfg. Operations*Grant or award+32,429——33,062Form 4
filed Robert P. ManfredoniaEVP of Sales and MarketingGrant or award+32,429——33,062Form 4
filed Daniel A. OttoChief Financial OfficerGrant or award+37,146——37,871Form 4
filed Lucille S. SalhanyDirectorGrant or award+11,006——11,114Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: 22Nd Century Group, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
1.2 M
1 days to cover
Reg SHO threshold list
15 days
in the last 90 days
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-57.8 reverse split ; 1-for-20 reverse split ; 1-for-14.99 reverse split ; 1-for-22.99 reverse split ; 1-for-135.14 reverse split ; 1-for-16 reverse split ; 1-for-14.99 reverse split

Trading halts

  • 2026-11-05 00:50 UTC, code T3, resumed 14:00 UTC
  • 2026-09-01 16:31 UTC, code LUDP, resumed 16:36 UTC
  • 2026-09-01 16:24 UTC, code LUDP, resumed 16:29 UTC
  • 2026-06-11 23:50 UTC, code T3, resumed 13:00 UTC
  • 2026-01-24 00:50 UTC, code T3, resumed 14:00 UTC

Fails to deliver

  • : 303,014 shares at $0.10
  • : 910,704 shares at $0.10
  • : 377,932 shares at $0.09
  • : 4.0 M shares at $0.20
  • : 3.9 M shares at $0.22

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

22Nd Century Group, Inc. scorecard#

Passes 7 of the 20 checks that could be worked out: strongest in financial health (3 of 5), weakest in growth (1 of 6). Fiscal year 2025; market cap of Oct 29, 2026.

  • Valuation2 of 4
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.0×Price to book 0.0× against Pharmaceutical's median of 3.2×.
    • ✓Price to sales below its peers' median0.0×Price to sales 0.0× against Pharmaceutical's median of 3.5×.
    • –Free cash flow yield above 5%No free cash flow yield on file.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 6
    • ✗Revenue grew in the newest year-27.9%Revenue down 27.9% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-24.3%-24.3% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-24.3%-24.3% a year against Pharmaceutical's median of 2.5% (65 companies).
    • ✗Earnings per share grew in the newest year-52.87 vs -45711.05Diluted EPS -52.87 in fiscal 2025 against -45711.05 the year before (report's currency).
    • ✓Net income higher than five years earlier-$5 M-$5 M in fiscal 2025 against -$20 M in 2020.
    • ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$5 MNet income -$5 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-65.8%-65.8% against Pharmaceutical's median of 1.8% (74 companies).
    • ✗Return on equity above 15%-51.1%-51.1% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-65.8%-65.8% in fiscal 2025 against -83.1% in 2022.
  • Financial health3 of 5
    • ✓Short-term assets cover short-term liabilities2.4×Current ratio 2.43 at the end of fiscal 2025.
    • ✓Debt below equity0.1×Debt to equity 0.05 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $6 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-20.95Z-score -20.95 (distress zone) for fiscal 2025.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from 22Nd Century Group, Inc.'s statements, beside the median of Pharmaceutical.

22Nd Century Group, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-65.8%1.8%
Net margin-28.7%-1.5%
Return on equity-51.1%-0.9%
Revenue growth, 3 years a year-24.3%2.5%
Revenue growth-27.9%7.3%
Debt to equity0.05×0.66×

4of 9on the Piotroski tests of financial strength

  • Revenue fell 27.9% against the year before.
  • Net loss of $5 million, the 16th loss-making year in a row.
  • Free cash flow was negative: -$8 million.
  • Receivables grew 111% while revenue grew -28%: customers are paying later, or sales were booked ahead of cash.

22Nd Century Group, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

22Nd Century Group, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue18243241r312826261712
Cost of revenue1014————26261713
Gross profit——————0.00.9−0.7−0.4
Research and development0.71.12.63.6r3.9—8.1153.42.3
Selling, general and administrative7.6103132r26r1513r8.6r8.3—
Selling and marketing———————0.91.21.6
General and administrative———————7.77.16.2
Operating expenses8.4123635r30r2124r25r1311
Operating income−12−14−45−34r−28−19−24r−24r−13−11
Interest expense and finance costs1.52.19.40.1r0.10.10.1r0.0r0.00.0
Share of profit of associates————————0.00.1
Other non-operating income (expense)−1.6−1.5−9.7−2.9r−4.2−0.5−3.0r16r0.3−0.2
Income before tax−13−15−55−37r−33−20−27r−8.0r−13−12
Income tax−0.00.00.00.0r0.00.00000
Income from continuing operations−13−15−55−37——————
Income from discontinued operations8.10.3−86−23——————
Net income including minority interests−5.1−15−141−60−33−20−27−8.0——
Net income attributable to shareholders−5.1−15−141−60−33−20−27r−8.0r−13−12
Earnings per share, basic-52.87-45,711.05r-15,925.99r-4.65r-0.21-0.14-0.21-0.06-0.13-0.15
Earnings per share, diluted-52.87-45,711.05r-15,925.99r-4.65r-0.21-0.14-0.21-0.06-0.13-0.15
Shares, weighted average (basic)0.20.0r0.0r13r15613912612410180
Shares, weighted average (diluted)0.20.0r0.0r13r156139126r124r10180
Balance sheet
Cash and cash equivalents7.14.42.13.0r1.31.00.5r0.63.713
Short-term investments———18472138r56590
Receivables3.61.71.71.4r0.62.20.9r0.91.00.0
Inventory4.32.04.37.3r2.92.02.3r3.03.33.1
Other current assets2.61.11.21.9r2.21.80.6r0.90.70.2
Current assets18121645542843r616817
Property, plant and equipment2.42.83.43.7r5.82.5r3.7r3.33.32.4
Right-of-use (leased) assets0.71.61.90.9r1.70.20.6r0——
Goodwill——0330—————
Other intangible assets6.25.75.97.2r7.98.28.5r9.87.47.4
Investments in associates—————————1.0
Long-term investments———0.72.36.58.4r3.11.41.0
Total assets272228115765269r778028
Accounts payable1.02.44.42.1r2.21.12.0r2.62.11.3
Debt due within a year—1.55.8———————
Current liabilities7.310.025138.47.35.8r5.24.33.2
Long-term debt—5.28.1———————
Lease liabilities (non-current)0.61.41.70.7r1.400.4r0——
Non-current liabilities——————1.1———
Total liabilities8.51836r199.97.66.9r6.04.33.3
Retained earnings−399−394−379−238−178−145−126r−99−91−78
Shareholders' equity164.0−8.496664462r71r75r24
Total liabilities and equity272228115765269r778028
Shares outstanding0.0r0.0r0.0r14r16313913812512491
Cash-flow statement
Depreciation and amortization———2.91.2—1.21.20.80.7
Share-based compensation0.40.42.75.54.01.73.5r3.2r0.90.9
Cash from operating activities−7.7−14−55−52−23−16−15r−18r−12−9.9
Capital expenditure−0.1−0.1−4.7−3.7−0.7−0.1−0.5———
Intangible assets bought−0.8−0.0−1.0−0.8−0.3−0.5−0.6r−0.7r−0.5−0.4
Acquisitions, net of cash acquired——−0.3−1.3——————
Cash from investing activities−0.5−0.11723−28164.6r15r−61−0.6
Debt issued——17——1.2————
Debt repaid−4.3−1.3−9.7——−1.2————
Shares issued—16—3540r—————
Cash from financing activities1117373151−0.39.9r−0.4r6320
Change in cash2.72.4−1.01.70.30.5−0.1r−3.1r−9.89.7
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What 22Nd Century Group, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Contract Manufacturing$17 M99%
  • Cigarettes$13 M73%
  • Filtered Cigars$4 M23%
  • Other tobacco products$0 M2.5%
  • VLN$0 M0.8%

Business segments

  • Single reportable segment$18 M100%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where 22Nd Century Group, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 12 subsidiaries on file.

22Nd Century Group, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office11 subsidiaries—
🇨🇦 Canada1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Events at 22Nd Century Group, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling

Auditor changed 1 · Directors and officers 3 · Material agreement 10 · Agreement ended 2 · Unregistered share sale 2 · Shareholder rights changed 8 · Bylaws or fiscal year changed 9 · Shareholder vote 4 · Results announced 8

22Nd Century Group, Inc.: events reported to the SEC
FiledWhat happenedFiling
Shareholder rights changedBylaws or fiscal year changed8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Agreement ended8-K
Shareholder vote8-K
Material agreementUnregistered share saleShareholder rights changedBylaws or fiscal year changed8-K
Material agreementUnregistered share saleShareholder rights changedBylaws or fiscal year changed8-K/A
Results announced8-K
Material agreement8-K
Results announced8-K
Material agreementShareholder rights changedBylaws or fiscal year changed8-K
Shareholder voteResults announced8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Material agreementShareholder rights changedBylaws or fiscal year changed8-K
Directors and officersMaterial agreementResults announced8-K
Agreement ended8-K
Auditor changed8-K
Material agreementShareholder rights changedBylaws or fiscal year changed8-K
Results announced8-K
Directors and officersBylaws or fiscal year changedShareholder vote8-K
Material agreement8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Directors and officersMaterial agreement8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 3, 2026

Acquisitions and funding#

3 private funding rounds before listing

Private share sales · funding history

Private share sales of 22Nd Century Group, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2024$1 MPrivate placement after listingUnder $2 million7equity, optionsSEC
Apr 2024$4 MPrivate placement after listing$2 to $10 million9equity, optionsSEC
Jul 2022$35 MPrivate placement after listing$10 to $50 million14equity, optionsSEC
May 2022$58 MPrivate placement after listing$50 to $250 million64equitySEC
Sep 2014$10 MPrivate placement after listing$10 to $50 million1equitySEC
Nov 2012$2 MNo. 3$2 to $10 million20equity, optionsSEC
May 2012$3 MNo. 2$2 to $10 million19equity, optionsSEC
Dec 2011$2 MNo. 1Under $2 million24debt, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by 22Nd Century Group, Inc.#

$0 spent on lobbying the US Congress and federal agencies in 2022.

Lobbying, 2022
$0
#1,465 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2022
2026 so far
—

Lobbying firms hired in 2022

Foley & Lardner, LLP

22Nd Century Group, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2022$0—1
2021$260 K—4
2020$70 K—1
2019$40 K—3
2018$120 K—5

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “22nd Century Group, Inc.” and “22nd Century”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

How 22Nd Century Group, Inc. compares in Pharmaceutical

  • Market cap$0 M · higher than 0% of 393
  • Revenue$18 M · higher than 8% of 324
  • Net margin-27.0% · higher than 12% of 313
  • Revenue growth-27.9% · higher than 8% of 107
  • Price / sales0.0× · lowest of 219
  • Price / book0.0× · lowest of 207

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
22Nd Century Group, Inc.🇺🇸$0 M—-27.0%-27.9%
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 29, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2020
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at 22Nd Century Group, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show 22Nd Century Group, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about 22Nd Century Group, Inc.? Suggest a correction